Stroke Prognostication using Age and NIH Stroke Scale: SPAN-100

Neurology

Volumn 80, Issue 1, 2013, Pages 21-28

  Saposnik, Gustavo ^a,f,g   Guzik, Amy K ^b   Reeves, Mathew ^c   Ovbiagele, Bruce ^d   Johnston, S Claiborne ^e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF SAN DIEGO   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BARTHEL INDEX; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; TREATMENT RESPONSE;

EID: 84873694532     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31827b1ace     Document Type: Article

References (25)

1. Weimar C, Konig IR, Kraywinkel K, Ziegler A, Diener HC. Age and National Institutes of Health Stroke Scale score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models. Stroke 2004;35:158-162.
2. Konig IR, Ziegler A, Bluhmki E, et al. Predicting long-term outcome after acute ischemic stroke: a simple index works in patients from controlled clinical trials. Stroke 2008;39:1821-1826.
3. Predicting outcome after acute ischemic stroke: an external validation of prognostic models. Neurology 2004;62:581-585.
4. Hacke W, Kaste M, Fieschi C, et al. Intravenous throm-bolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 1995;274:1017-1025.
5. Hacke W, Kaste M, Fieschi C, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II): Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
6. Clark WM, Albers GW, Madden KP, Hamilton S. The rtPA (alteplase) 0-to 6-hour acute stroke trial, part A (a0276g): results of a double-blind, placebo-controlled, multicenter study: Thrombolytic Therapy in Acute Ischemic Stroke Study Investigators. Stroke 2000;31: 811-816.
7. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
8. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
9. Mishra NK, Ahmed N, Andersen G, et al. Thrombolysis in very elderly people: controlled comparison of SITS international stroke thrombolysis registry and virtual international stroke trials archive. BMJ 2010;341:c6046.
10. Sylaja PN, Cote R, Buchan AM, Hill MD. Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study. J Neurol Neurosurg Psychiatry 2006;77:826-829.
11. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA 2005;293:1223-1238.
12. Saposnik G, Cote R, Phillips S, et al. Stroke outcome in those over 80: a multicenter cohort study across Canada. Stroke 2008;39:2310-2317.
13. Kent DM, Selker HP, Ruthazer R, Bluhmki E, Hacke W. The stroke-thrombolytic predictive instrument: a predictive instrument for intravenous thrombolysis in acute ischemic stroke. Stroke 2006;37:2957-2962.
14. Saposnik G, Kapral MK, Liu Y, et al. iScore: a risk score to predict death early after hospitalization for an acute ischemic stroke. Circulation 2011;123:739-749.
15. Strbian D, Meretoja A, Ahlhelm FJ, et al. Predicting outcome of IV thrombolysis-treated ischemic stroke patients: the DRAGON score. Neurology 2012;78:427-432.
16. The NINDS t-PA Stroke Study Group. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. Stroke 1997;28:2109-2118.
17. Saposnik G, Young B, Silver B, et al. Lack of improvement in patients with acute stroke after treatment with thrombolytic therapy: predictors and association with outcome. JAMA 2004;292:1839-1844.
18. Altman DG. Confidence intervals for the number needed to treat. BMJ 1998;317:1309-1312.
19. Lou M, Safdar A, Mehdiratta M, et al. The HAT score: a simple grading scale for predicting hemorrhage after throm-bolysis. Neurology 2008;71:1417-1423.
20. Ntaios G, Faouzi M, Ferrari J, Lang W, Vemmos K, Michel P. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology 2012;78:1916-1922.
21. Saposnik G, Fang J, Kapral MK, et al. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke. Stroke 2012;43:1315-1322.
22. Guzik AK, Raman R, Ernstron K, et al. Clinical outcomes of the 'Stroke 100 club.' Stroke 2012;43:A3572.
23. Saposnik G, Raptis S, Kapral MK, et al. The iScore predicts poor functional outcomes early after hospitalization for an acute ischemic stroke. Stroke 2011;42: 3421-3428.
24. Saposnik G, Demchuk A, Tu JV, Johnston SC, Stroke Outcomes Research Canada (SORCan) Working Group. The iScore predicts efficacy and risk of bleeding in the National Institute of Neurological Disorders and Stroke tissue plasminogen activator stroke trial. J Stroke Cerebrovasc Dis Epub 2012 Oct 24.
25. Merino JG, Silver B, Wong E, Demaerschalk B, Tamayo A, Hachinski V. Physician knowledge of the benefits, risks, and contraindications of tissue plasminogen activator for acute ischemic stroke. Stroke 2001;32:2208-2209.